Transjugular intrahepatic portosystemic shunt for hepatitis C virus-related portal hypertension after liver transplantation

Clinical Transplantation

Volumn 26, Issue 5, 2012, Pages 699-705

  Ghinolfi, Davide ^a   De Simone, Paolo ^a   Catalano, Gabriele ^a   Petruccelli, Stefania ^a   Coletti, Laura ^a   Carrai, Paola ^a   Marti, Josep ^b   Tincani, Giovanni ^a   Cicorelli, Antonio ^a   Cioni, Roberto ^a   Filipponi, Franco ^a  

^a CISANELLO HOSPITAL   (Italy)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Complications; Liver transplantation; Outcome; Surgery cadaveric; Transjugular intrahepatic portosystemic shunt

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYDROTHORAX; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; MORTALITY; PORTAL HYPERTENSION; PRIORITY JOURNAL; RECURRENT DISEASE; SAFETY; SEPSIS; SURVIVAL RATE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT DURATION; TREATMENT INDICATION;

AGED; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HUMANS; HYPERTENSION, PORTAL; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE;

EID: 84867655605     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01595.x     Document Type: Article

References (26)

1. Rosch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology 1969: 92: 1112.
2. Richter GM, Palmaz JC, Noldge G et al. The transjugular intrahepatic portosystemic stant-shunt. A new non-surgical percutaneous method. Radiologe 1989: 29: 406.
3. Choi DX, Jain AB, Orloff MS. Utility of transjugular intrahepatic portosystemic shunts in liver transplant recipients. J Am Coll Surg 2009: 208: 539.
4. Rössle M, Gerbes AL. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut 2010: 59: 988.
5. García-Pagán JC, Caca K, Bureau C et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010: 362: 2370.
6. Finkenstedt A, Graziadei I, Nachbaur K et al. Transjugular intrahepatic portosystemic shunt in liver transplant recipients. World J Gastroenterol 2009: 15: 1999.
7. Kim JJ, Dasika NL, Yu E, Fontana R. Transjugular intrahepatic portosystemic shunts in liver transplant recipients. Liver Int 2008: 28: 240.
8. Richard HM, Cooper JM, Ahn J et al. Transjugular intrahepatic portosystemic shunts in the management of Budd-Chiari syndrome in the liver transplant patient with intractable ascites: anatomic considerations. J Vasc Interv Radiol 1998: 9: 137.
9. Lerut JP, Laterre PF, Goffette P et al. Transjugular intrahepatic portosystemic shunt and liver transplantation. Transp Int 1996: 9: 370.
10. Somberg KA, Lombardero MS, Lawlor SM et al.A controlled analysis of the transjugular intrahepatic portosystemic shunt in liver transplant recipients. Transplantation 1997: 63: 1074.
11. Nolte W, Canelo R, Figula HR et al. Transjugular intrahepatic portosystemic shunt after orthotopic liver transplantation in a patient with early recurrence of portal hypertension of unknown origin. Z Gastroeterol 1998: 36: 159.
12. Amesur NB, Zajko AB, Orons P, Sammon JK, Casavilla FA. Transjugular intrahepatic portosystemic shunt in patients who have undergone liver transplantation. J Vasc Interv Radiol 1999: 10: 569.
13. Abouljoud M, Yoshida A, Kim D et al. Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation. Transplant Proc 2005: 37: 1248.
14. Van Ha TG, Funaki BS, Ehrhardt J et al. Transjugular intrahepatic portosystemic shunt placement in liver transplant recipients: experiences with pediatric and adult patients. Am J Roentgenol 2005: 184: 920.
15. Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl 2002: 8(10 Suppl 1): S14.
16. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981: 1: 431.
17. Moore KP, Wong F, Gines P et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003: 38: 258.
18. Dindo D, Desmartines N, Clavien PA. Classification of surgical complications. A new proposal with evaluation in a color of 6336 patients and results of a survey. Ann Surg 2004: 240: 205.
19. Unos database. Available at: http://www.unos.org.
20. Verna EC, Brown RS. Hepatitis C and liver transplantation: enhancing outcomes and should patients be retransplanted. Clin Liver Dis 2008: 12: 637.
21. Watt KD, Lyden ER, Mccashland TM. Poor survival after liver transplantation: is hepatitis C to blame?Liver Transpl 2003: 9: 1019.
22. Pelletier SJ, Schaubel DE, Punch JD et al. Hepatitis C is a risk factor for death after liver retransplantation. Liver Transpl 2005: 11: 434.
23. Rosen HR, Madden JP, Martin P. A model to predict survival following liver retransplantation. Hepatology 1999: 29: 365.
24. Saad WE, Darwish WM, Davies MG, Waldman DL. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome. J Vasc Interv Radiol 2010: 21: 218.
25. King A, Masterton G, Gunson B et al.A case-controlled study of the safety and efficacy of transjugular intrahepatic portosystemic shunts after liver transplantation. Liver Transpl 2011: 17: 771.
26. Feyssa E, Ortiz J, Grewal K et al. MELD score less than 15 predicts prolonged survival after transjugular intrahepatic portosystemic shunt for refractory ascites after liver transplantation. Transplantation 2011: 91: 786.